Health Management Associates
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Health Management Associates's revenues will expand 1.0% and EPS will decrease -58.3%.
The average estimate for revenue is $1.70 billion. On the bottom line, the average EPS estimate is $0.10.
Last quarter, Health Management Associates logged revenue of $1.72 billion. GAAP reported sales were 6.6% higher than the prior-year quarter's $1.39 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.12. GAAP EPS of $0.18 for Q4 were 50% higher than the prior-year quarter's $0.12 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 38.8%, 30 basis points better than the prior-year quarter. Operating margin was 10.9%, 10 basis points better than the prior-year quarter. Net margin was 3.3%, 110 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $6.96 billion. The average EPS estimate is $0.85.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 214 members out of 255 rating the stock outperform, and 41 members rating it underperform. Among 83 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 75 give Health Management Associates a green thumbs-up, and eight give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Health Management Associates is outperform, with an average price target of $9.10.
Is Health Management Associates the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Health Management Associates to My Watchlist.